Neurocentre Magendie - UMR-S 1215
Créé en janvier 2007, le Neurocentre Magendie compte aujourd'hui environ 220 chercheurs, enseignants-chercheurs, techniciens, post-doctorants et étudiants, répartis dans 11 équipes de recherche et 6 plateformes techniques communes. Riches d'une dizaine de nationalités différentes, les membres du centre de recherche disposent de 12000 m² au cœur du campus de Carreire. Associés au Neurocentre Magendie, 6 autres unités de recherche composent la Fédération Bordeaux Neurocampus qui totalise ainsi 700 personnes de 20 nationalités dans 50 équipes et décuple les ressources et les capacités d'investigation et de formation de notre communauté.
Browse by
Recent Submissions
-
Epidemics and outbreaks of peripheral nervous system disorders: II. Toxic and nutritional causes
(Journal of Neurology. vol. 268, n° 3, pp. 892-902, 2021-03)Article de revueOpen access -
Epidemics and outbreaks of peripheral nervous system disorders: I. infectious and immune-mediated causes
(Journal of Neurology. vol. 268, n° 3, pp. 879-890, 2021-03)Article de revueOpen access -
PAI-1 protein is a key molecular effector in the transition from normal to PTSD-like fear memory
(Molecular Psychiatry. vol. 26, n° 9, pp. 4968-4981, 2021-09)Article de revueOpen access -
French validation of the Brief International Cognitive Assessment for Multiple Sclerosis
(Revue Neurologique. vol. 177, n° 1-2, pp. 73-79, 2021-01)Article de revue -
Determinants of therapeutic lag in multiple sclerosis
(Multiple Sclerosis Journal. vol. 27, n° 12, pp. 1838-1851, 2021-10)Article de revueOpen access -
Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis
(Neurotherapeutics. vol. 18, n° 1, pp. 378-386, 2021-01)Article de revueOpen access -
Serotonin modulation of hippocampal functions: From anatomy to neurotherapeutics
(Elsevier, 2021)Chapitre d'ouvrage -
Somatostatin receptor ligands induce TSH deficiency in thyrotropin-secreting pituitary adenoma
(European journal of endocrinology. vol. 184, n° 1, pp. 1-8, 2021-01)Article de revue -
Multiple facets of serotonergic modulation
(Elsevier, 2021)Chapitre d'ouvrage -
Serotonin 2B Receptor Interactions with Dopamine Network: Implications for Therapeutics in Schizophrenia
(Springer, 2021)Chapitre d'ouvrage -
(Re)contextualizing the Trauma to Prevent or Treat PTSD-Related Hypermnesia
(Chronic Stress. vol. 5, 2021-05-26)Article de revueOpen access -
A Baldwin interpretation of adult hippocampal neurogenesis: from functional relevance to physiopathology
(Molecular Psychiatry. vol. 27, n° 1, pp. 383-402, 2022-01)Article de revueOpen access -
Cerebral mucormycosis: neuroimaging findings and histopathological correlation
(Journal of Neurology. vol. 269, n° 3, pp. 1386-1395, 2022-03)Article de revue -
New perspectives on the role of the neurosteroid pregnenolone as an endogenous regulator of type-1 cannabinoid receptor (CB1R) activity and function
(Journal of Neuroendocrinology. vol. 34, n° 2, 2022-02)Article de revue -
A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica
(Annals of Clinical and Translational Neurology. vol. 8, n° 10, pp. 2025-2037, 2021-10)Article de revueOpen access -
The temporal origin of dentate granule neurons dictates their role in spatial memory
(Molecular Psychiatry, 2021-12)Article de revueOpen access -
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
(CNS drugs. vol. 35, n° 11, pp. 1217-1232, 2021-11)Article de revue -
The atypical Rho GTPase Rnd2 is critical for dentate granule neuron development and anxiety-like behavior during adult but not neonatal neurogenesis
(Molecular Psychiatry. vol. 26, n° 12, pp. 7280–7295, 2021-09-24)Article de revueOpen access -
Embolization as adjunctive treatment to achieve complete cure of ruptured arachnoid cyst associated with chronic subdural hematoma
(British Journal of Neurosurgery, 2021-09-25)Article de revue -
Comparative effectiveness of dimethyl fumarate in multiple sclerosis
(British Journal of Clinical Pharmacology, 2021-03)Article de revueOpen access
Statistics
Collection General Statistics
Typology History
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Article de revue | 3 | 3 | 5 | 74 | 4 |
Autre communication scientifique (congrès sans actes - poster - séminaire...) | 0 | 0 | 0 | 0 | 0 |
Autre document | 0 | 0 | 0 | 0 | 0 |
Brevet | 0 | 0 | 0 | 0 | 0 |
Chapitre d'ouvrage | 0 | 0 | 0 | 3 | 0 |
Communication dans un congrès avec actes | 0 | 0 | 0 | 0 | 0 |
Direction d'ouvrage | 0 | 0 | 0 | 0 | 0 |
Document de travail - Pré-publication | 0 | 0 | 0 | 0 | 0 |
HDR | 0 | 0 | 0 | 0 | 0 |
Ouvrage | 0 | 0 | 0 | 0 | 0 |
Rapport | 0 | 0 | 0 | 0 | 0 |
Thèse d'exercice | 0 | 0 | 0 | 0 | 0 |
Thèses de doctorat | 1 | 0 | 0 | 0 | 0 |